# Flavonoid Supplementation and Endothelial Function

> **NCT00331227** · PHASE4 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 25 (—)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Isotonix OPC-3 (flavonoid supplement)

## Key facts

- **NCT ID:** NCT00331227
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 25 (—)
- **Last updated:** 2022-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00331227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00331227, "Flavonoid Supplementation and Endothelial Function". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT00331227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*